U.S. markets close in 2 hours 19 minutes

Wuhan General Group (China), Inc. (WUHN)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.6900-0.0100 (-1.43%)
As of 1:07PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.7000
Open0.7050
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.6900 - 0.7050
52 Week Range0.0200 - 1.0900
Volume3,744
Avg. Volume83,350
Market Cap3.01M
Beta (5Y Monthly)2.49
PE Ratio (TTM)N/A
EPS (TTM)-0.3480
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Liviana Artisanal CBD Olive Oils Have Arrived
    ACCESSWIRE

    Liviana Artisanal CBD Olive Oils Have Arrived

    CAPE TOWN, SA / ACCESSWIRE / May 7, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("Wuhan" or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to announce the following update:The Liviana CBD Infused Extra Virgin Olive Oils first batch is ready to hit the shelves.

  • Wuhan General Group Secures Lab for Hemp and Mycelium Eco-Friendly Research & Development
    ACCESSWIRE

    Wuhan General Group Secures Lab for Hemp and Mycelium Eco-Friendly Research & Development

    CAPE TOWN, SA / ACCESSWIRE / May 5, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("Wuhan" or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to announce the following update:The hemp and mycelium eco-friendly R&D division of M2Bio Sciences, has secured a laboratory facility near its Woodstock office in Cape Town, South Africa.

  • ACCESSWIRE

    Wuhan General Group Recruiting in Lesotho for its Medicinal Cannabis Cultivation Facility

    CAPE TOWN, SA / ACCESSWIRE / April 20, 2021 / WUHAN GENERAL GROUP, INC. (WUHN) ("Wuhan'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to announce on the occasion of ‘420 Day' or ‘Weed Day' that the company, through its local subsidiary, Tsime Pharmaceuticals and Medicinal Supplies, has started recruiting its team for the rollout of a world class medicinal cannabis cultivation facility.